Abstract
Aims-Children in a United Kingdom national trial for relapsed non-B lymphoblastic leukaemia (ALL) had their diagnostic and relapse marrow cytomorphology compared to see what changes occur during the evolution of the disease. Methods-Each relapse slide was assessed blindly for French American British (FAB) type and other morphological features by a panel of three independent microscopists without reference to each other or any diagnostic material. Diagnostic slides had been assessed by the same panel on an earlier occasion. Results-A total of 134 consecutive children was studied. Six (5%) were classified as FAB type L2 at diagnosis, compared with 18 (13%) at relapse (a difference of 9%/6). Twenty two (16%) changed their FAB type, 17 (13%) from LI to L2 and five (4%) from L2 to LI. The FAB score fell at relapse in 34 children and rose in 14, a difference of 14%. Cell size was the commonest feature to change (increasing in 22 and diminishing in nine) followed by prominent nucleoli (appearing in 21 The cytomorphological classification of non-B childhood lymphoblastic leukaemia (ALL) is traditionally based on the system suggested by the French American British (FAB) group' and pivots around four features: nuclear:cytoplasmic (NC) ratio, nucleoli, nuclear shape, and cell size. The FAB type is based on a scoring system where a low NC ratio, prominent nucleoli, irregular nuclear membrane, and large size contribute to an L2 classification, whereas their absence leads to an Li classification. LI features score positively and L2 features negatively, so a high score types as Li and a low score as L2.
At diagnosis, only some 11% of children will have a score leading to their being dubbed L2. They may have an inferior response to therapy, but FAB type does not seem to be a prognostic variable independent of better known discriminants such as age, sex and diagnostic white cell count.
Other morphological features such as the presence of cytoplasmic vacuoles and so-called "hand mirror" cells have also attracted attention as well as the FAB type, and vacuoles seem to be associated with a better outcome. The variability and clinical importance of all of these cytomorphological features at diagnosis have recently been studied in a large cohort of children in UK national trials. 2 The question whether morphological appearances change at the time of relapse has been largely ignored. A small study 15 years ago suggested that there was a major shift from Li to L2 with no patients making the reverse change.3 Two later studies produced conflicting results,45 but all three described relatively small numbers of patients. To revisit the question on a larger scale we decided to compare the morphology at diagnosis and subsequent marrow relapse in a group of children in a nationwide UK trial for recurrent ALL. 1  7  6  1  1  2  2  2  7  5  1  2  1  2  3  7  6  1  1  1  3  4  5  3  1  3  1  3  5  7  6  1  1  1  3  6  5  4  1  2  1  3  7  6  4  1  3  1  2  8  7  5  1  1  1  3  9  7  5  1  2  1  1  10  7  4  1  3  1  2  11  7  5  1  2  1  1  12  7  5  1  2  2  1  13  7  5  1  2  1  2  14  7  4  1  1  1  3  15  7  6  1  1  1  3  16  7  6  1  1  1  3  17  7  5  1  3  1  1  18  7  4  1  4  1  3  19  5  3  2  2  1  1  20  6  3  1  1  1  3  21  7  2  1  2  1  3  22  7  6  1  1  1  2  23  7  6  1  1  1  2  24  7  5  1  2  1  1  25  7  5  1  2  1  1  26  7  5  1  2  1  2  27  7  2  1  3  1  3  28  5  3  3  2  2  1  29  7  4  1  1 
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Total score and scores for most frequently different features (for explanation ofscoring see 
Discussion
The findings of this study, the largest to date comparing the morphology at diagnosis and later relapse in childhood ALL, reflect the variability ofblast cell appearances during the evolution of the disease. There was a detectable and probably statistically significant trend for cells to acquire L2 characteristics more frequently than other changes as the disease progressed. The commonest features to alter were cell size (cells tended to become larger) and the presence of nucleoli (these tended to appear).
Such findings should be interpreted cautiously. As Romanowsky stained smears are, in essence, controlled artefacts, and because that control is easily lost when the smear is badly made, hypocellular or hypercellular (or when the process of staining is carried out with insufficient skill), it is dangerous to conclude too much from apparent changes in blast cell characteristics in small numbers of patients.
Concordance between the observers in the present study was generally excellent, but slides of borderline adequacy were the ones that caused the most trouble.
So far the evolution of blast cell morphology in ALL has been little studied. There are three previous reports of which we are aware. The Changes in cytomorphology of childhood ALL at disease relapse 1  6  7  1  1  1  1  2  6  7  1  1  2  1  3  2  7  2  1  2  1  4  6  7  1  1  2  1  5  4  7  1  1  3  1  6  5  6  3  1  1  3  7  6  7  1  1  3  1  8  4  7  3  1  2  1  9  6  7  1  1  3  1  10  5  7  2  1  1  1  11  4  7  2  1  2  1  12  6  7  1  1  1  2  13  2  7  2  1  3  1  14  5  7  3  1  1  1 Total score and scores for most frequently different features (for explanation ofscoring see Just what FAB and other morphological features of lymphoblasts represent in terms of cell lineage or status is not clear. There is little to suggest that they identify biologically distinct subtypes of the disease as they are well represented within-for example, all the main immunophenotypes.2 As children at the time of marrow relapse are likely to be picked up at an earlier stage of tumour (re)growth, a point underlined by the higher proportion of cells to be found in the S phase of mitosis at relapse when compared with diagnosis,89 it seems possible that at least some of the characteristics that determine L2 morphology (cell size and the prominence of nucleoli, for example) may simply reflect the growth fraction of the malignant cell population rather than any disease specific association.
